Cargando…

Factors associated with contraceptive use among women living with HIV in Canada: a controlled, cross-sectional study

BACKGROUND: Multiple contraindications to combined hormonal contraceptives (CHC) use exist. The impact of these factors on contraceptive choice, particularly among women living with HIV (WLWH), is not well understood. We measured and compared the prevalence of contraceptive use and contraindications...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khondoker, Chadni C., Kaida, Angela, Marquez, Anna, Campbell, Amber R., Côté, Hélène C. F., Albert, Arianne Y., Pick, Neora, Maan, Evelyn J., Russell, Emilie A. B., Prior, Jerilynn C., Elwood, Chelsea, Brophy, Jason, Murray, Melanie C. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729076/ https://www.ncbi.nlm.nih.gov/pubmed/34986848 http://dx.doi.org/10.1186/s12978-021-01312-7

Ejemplares similares

322. Prolonged Amenorrhea Is Associated with Decreased Hip Bone Mineral Density in Women Living with HIV
por: King, Elizabeth, et al.
Publicado: (2019)

Long‐Term Change in Bone Mineral Density in Women Living With HIV: A 10‐Year Prospective Controlled Cohort Study
por: Macdonald, Heather M., et al.
Publicado: (2023)

Age at Natural Menopause in Women Living with HIV: A Cross-Sectional Study Comparing Self-Reported and Biochemical Data
por: Swann, Shayda A., et al.
Publicado: (2023)

Lower anti-Müllerian hormone levels are associated with HIV in reproductive age women and shorter leukocyte telomere length among late reproductive age women
por: Van Ommen, Clara E., et al.
Publicado: (2023)

British Columbia CARMA-CHIWOS Collaboration (BCC3): protocol for a community-collaborative cohort study examining healthy ageing with and for women living with HIV
por: Swann, Shayda A, et al.
Publicado: (2021)

Premature Spinal Bone Loss in Women Living with HIV is Associated with Shorter Leukocyte Telomere Length
por: Kalyan, Shirin, et al.
Publicado: (2018)

Health Care Provider Utilization and Cost of an mHealth Intervention in Vulnerable People Living With HIV in Vancouver, Canada: Prospective Study
por: Campbell, Amber R, et al.
Publicado: (2018)

Exploring the live birth rates of women living with HIV in British Columbia, Canada
por: Van Ommen, Clara E., et al.
Publicado: (2019)

Select Neurocognitive Impairment in HIV-Infected Women: Associations with HIV Viral Load, Hepatitis C Virus, and Depression, but Not Leukocyte Telomere Length
por: Giesbrecht, Chantelle J., et al.
Publicado: (2014)

Robust tobacco smoking self-report in two cohorts: pregnant women or men and women living with or without HIV
por: Smith, Marie-Soleil R., et al.
Publicado: (2023)

Inverse relationship between leukocyte telomere length attrition and blood mitochondrial DNA content loss over time
por: Hsieh, Anthony Y.Y., et al.
Publicado: (2020)

HOW CAN WE PROTECT PEAK BONE MASS AND FUTURE BONE HEALTH FOR ADOLESCENT WOMEN? - BY SUPPORTING OVULATION AND AVOIDING COMBINED HORMONAL CONTRACEPTION USE
por: Prior, Jerilynn Celia
Publicado: (2017)

Combined hormonal contraceptives use and bone mineral density changes in adolescent and young women in a prospective population-based Canada-wide observational study
por: Brajic, Tatjana S., et al.
Publicado: (2018)

Competing Factors Link to Bone Health in Polycystic Ovary Syndrome: Chronic Low-Grade Inflammation Takes a Toll
por: Kalyan, Shirin, et al.
Publicado: (2017)

Gender Inequities in Quality of Care among HIV-Positive Individuals Initiating Antiretroviral Treatment in British Columbia, Canada (2000–2010)
por: Carter, Allison, et al.
Publicado: (2014)

High rates of posttraumatic stress symptoms in women living with HIV in Canada
por: Wagner, Anne C., et al.
Publicado: (2018)

Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures Study
por: King, Elizabeth, et al.
Publicado: (2017)

Innovations in Women’s Bone Health—Appreciating Important “Bone Variables” Besides Estrogen
por: Prior, Jerilynn C.
Publicado: (2018)

Adaptive, reversible, hypothalamic reproductive suppression: More than functional hypothalamic amenorrhea
por: Prior, Jerilynn C.
Publicado: (2022)

Adolescent use of combined hormonal contraception and peak bone mineral density accrual: A meta‐analysis of international prospective controlled studies
por: Goshtasebi, Azita, et al.
Publicado: (2019)

Pregnancy incidence and intention after HIV diagnosis among women living with HIV in Canada
por: Salters, Kate, et al.
Publicado: (2017)

Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples
por: Racey, C Sarai, et al.
Publicado: (2022)

Intention to Receive a COVID-19 Vaccine by HIV Status Among a Population-Based Sample of Women and Gender Diverse Individuals in British Columbia, Canada
por: Kaida, Angela, et al.
Publicado: (2022)

Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial
por: Prior, Jerilynn C., et al.
Publicado: (2023)

Progesterone and Bone: Actions Promoting Bone Health in Women
por: Seifert-Klauss, Vanadin, et al.
Publicado: (2010)

Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS)—A 6-Month Pilot Study of a Single Woman’s Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2021)

Assessing the role of adolescent hormonal contraceptive use on risk for depression: a 3-year longitudinal study protocol
por: Zareian, Bita, et al.
Publicado: (2022)

Emergency contraception subsidy in Canada: a comparative policy analysis
por: Lee, Sabrina C., et al.
Publicado: (2022)

Discussing reproductive goals with healthcare providers among women living with HIV in Canada: the role of provider gender and patient comfort
por: Skerritt, Lashanda, et al.
Publicado: (2021)

Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study.
por: Gallagher, R. P., et al.
Publicado: (1985)

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2020)

Ovulation Prevalence in Women with Spontaneous Normal-Length Menstrual Cycles – A Population-Based Cohort from HUNT3, Norway
por: Prior, Jerilynn C., et al.
Publicado: (2015)

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature
por: Shirin, Sonia, et al.
Publicado: (2020)

A one-year observational cohort study of menstrual cramps and ovulation in healthy, normally ovulating women
por: Bann, Sewon, et al.
Publicado: (2022)

Women's Health Care Utilization among Harder-to-Reach HIV-Infected Women ever on Antiretroviral Therapy in British Columbia
por: Wang, Xuetao, et al.
Publicado: (2012)

Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada
por: Ogilvie, Gina S., et al.
Publicado: (2021)

Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)
por: Wong, Evelyn M. M., et al.
Publicado: (2018)

Screening of Compounds Toxicity against Human Monocytic cell line-THP-1 by Flow Cytometry
por: Pick, Neora, et al.
Publicado: (2004)

Barriers To Accessing Contraception and Cervical and Breast Cancer Screening During COVID-19: A Prospective Cohort Study
por: Baaske, Alexandra, et al.
Publicado: (2022)

Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV–HCV coinfected patients
por: Emery, Joel, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_v5jkcj35lsdnvlkgr2tkire0do